Abstracts Archive - Page 2274 of 2425 - ACR Meeting Abstracts

Abstract Number: 2236 • 2012 ACR/ARHP Annual Meeting
Cross Cultural Validation of English and French Versions of a Disease Specific Patient Reported Outcome Measure for Lupus in Canada
Josiane Bourré-Tessier¹, Ann E. Clarke², Rachel A. Mikolaitis³, Mark Kosinski⁴, Sasha Bernatsky⁵, Joel A. Block³ and Meenakshi Jolly⁶, ¹Rheumatology, McGill University, Montréal, QC, Canada, ²Clinical Epidemiology, McGill University, Montreal, QC, Canada, ³Section of Rheumatology, Rush University Medical Center, Chicago, IL, ⁴QualityMetric Inc, Lincoln, RI, ⁵McGill University, Montreal, QC, Canada, ⁶Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: The LupusPRO, a disease targeted Patient Reported Outcome measure, was developed and validated in US patients with Systemic Lupus Erythematosus (SLE). We aimed to…
Abstract Number: 2237 • 2012 ACR/ARHP Annual Meeting
Application and Feasibility of Proposed Systemic Lupus Erythematosus Reproductive Health Care Quality Indicators At a Public Urban Rheumatology Clinic
Itziar Quinzanos¹, Angela Keniston², Joann Zell³, Jinoos Yazdany⁴, Alyssa Nash¹, Rebecca Fransen¹, Jennifer Stichman¹ and Joel M. Hirsh⁵, ¹Dept Medicine, Denver Health Med Ctr, Denver, CO, ²Department of Medicine, Denver Health and Hospital Authority, Denver, CO, ³Medicine, National Jewish Health, Denver, CO, ⁴Medicine, University of California, San Francisco, San Francisco, CA, ⁵Medicine, Division of Rheumatology, Denver Health and Hospital Authority, Denver, CO
Background/Purpose: Reproductive health quality indicators (QIs) for systemic lupus erythematosus (SLE) have recently been developed: anti-ssA, anti-ssB, and phospholipid antibody (aPL) screening prior to pregnancy;…
Abstract Number: 2238 • 2012 ACR/ARHP Annual Meeting
Alpha-Chlorofatty Acid Does Not Correlate with Baseline Subclinical Cardiovascular Disease in Systemic Lupus Erythematosus
Mary A. Mahieu¹, Camelia Guild², Carolyn J. Albert³, George Kondos⁴, James Carr⁵, Daniel Edmundowicz⁶, David A. Ford⁷ and Rosalind Ramsey-Goldman⁸, ¹Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, ²Pediatrics and Center for Outcomes Research, Saint Louis University, Saint Louis, MO, ³Saint Louis University, Saint Louis, MO, ⁴University of Illinois at Chicago, Chicago, IL, ⁵Northwestern University Feinberg School of Medicine, Chicago, IL, ⁶Temple University School of Medicine, Philadelphia, PA, ⁷Department of Biochemistry and Molecular Biology, Saint Louis University, Saint Louis, MO, ⁸Medicine/Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL
Background/Purpose: Serum alpha-chlorofatty acid (α-ClFA) directly reflects in vivo myeloperoxidase activity, an important regulator of atherogenesis. The objective of our study was to investigate whether α-ClFA…
Abstract Number: 2239 • 2012 ACR/ARHP Annual Meeting
Characterization of Pure Membranous Lupus Nephritis: A Cohort of 150 Patients
Lucía Silva¹, Teresa Oton¹, Anca Askanase², Patricia Carreira³, Francisco Javier López-Longo⁴, Anne Riveros⁵, Íñigo Rúa-Figueroa⁶, Javier Narvaez⁷, Esther Ruiz-Lucea⁸, Mariano Andres⁹, Enrique Calvo¹⁰, Francisco Toyos¹¹, Juan J. Alegre¹², Eva Tomero¹³, Carlos Montilla¹⁴, Antonio Zea¹⁵, Esther Uriarte-Isacelaya¹⁶, Jaime Calvo-Alen¹⁷, Carlos Marras¹⁸, Víctor M. Martínez-Taboada¹⁹, María Ángeles Belmonte²⁰, Jose Rosas²¹, Enrique Raya²², Gema Bonilla²³ and Mercedes Freire²⁴, ¹Rheumatology, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda (Madrid), Spain, ²NYU School of Medicine, New York, NY, ³Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, ⁴Hospital General Universitario Gregorio Marañón, Department of Rheumatology, Madrid, Spain, ⁵Rheumatology, Hospital Universitario Germans Trias i Pujol, Badalona, Spain, ⁶Rheumatology, Hospital Universitario Dr Negrín. Las Palmas, Las Palmas de Gran Canaria, Spain, ⁷Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, ⁸Rheumatology, Hospital de Basurto, Bilbao, Spain, ⁹Seccion Reumatologia, Hospital General Universitario de Alicante, Alicante, Spain, ¹⁰Rheumatology, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Spain, ¹¹Rheumatology, Hospital Universitario Virgen Macarena, Sevilla, Spain, ¹²Rheumatology, Hospital Universitario Dr Peset, Valencia, Spain, ¹³Rheumatology, Hospital Universitario de La Princesa. IIS La Princesa, Madrid, Spain, ¹⁴Unit Rheumatology, Hospital Universitario de Salamanca, Salamanca, Spain, ¹⁵Rheumatology, Hospital Universitario Ramon y Cajal, Madrid, Spain, ¹⁶Rheumatology, Hospital Universitario de Donostia, Donosti, Spain, ¹⁷Rheumatology, Hospital Sierrallana. Torrelavega, Torrelavega, Spain, ¹⁸Rheumatology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain, ¹⁹Rheumatology, Hospital Universitario Marqués de Valdecilla. IFIMAV, Santander, Spain, ²⁰Rheumatology, Hospital Universitario Carlos Haya, Málaga, Spain, ²¹Rheumatology, Hospital Marina Baixa. Villajoyosa, Villajoyosa, Spain, ²²Rheumatology, University Hospital San Cecilio, Granada, Spain, ²³Rheumatology, Hospital La Paz, Madrid, Spain, ²⁴Rheumatology, Hospital Universitario Juan Canalejo, La Coruña, Spain
Background/Purpose : Over 50% of patients with SLE develop renal involvement but only 20% of these are found to have pure membranous lupus neprhitis (MLN)…
Abstract Number: 2240 • 2012 ACR/ARHP Annual Meeting
Systematic Review of Skin Nontuberculous Mycobacteria Infection in Systemic Lupus Erythematosus: An Unusual Skin Infection Mimicking Lupus Vasculitis
Zahi Touma¹, Amir Haddad², Dafna D. Gladman³, Elizabeth Uleryk⁴ and Murray B. Urowitz⁵, ¹Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, ³Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Research Institute, University of Toronto, University Health Network, Toronto, ON, Canada, ⁴Hospital Library and Archives, The Hospital for Sick Children, Toronto, ON, Canada, ⁵Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada
Background/Purpose: Nontuberculous mycobacteria (NTM) have become pathogens frequently associated with skin infection in patients on immunosuppression. NTM is not unusual in lupus patients and the…
Abstract Number: 2241 • 2012 ACR/ARHP Annual Meeting
Efficacy of Belimumab in Systemic Lupus Erythematosus Patients with High Baseline Disease Activity
Ann E. Clarke¹, Susan Manzi², Michelle Petri³, Richard Furie⁴, Ronald F. van Vollenhoven⁵, Simon Cooper⁶, Z. John Zhong⁶, William W. Freimuth⁶ and Arthur Weinstein⁷, ¹Division of Rheumatology, University of Calgary, Alberta, Calgary, AB, Canada, ²Division of Rheumatology, University of Pittsburgh School of Medicine, Pittsburgh, PA, ³Johns Hopkins University School of Medicine, Baltimore, MD, ⁴North Shore-LIJ Health System, Lake Success, NY, ⁵Karolinska University Hospital, Stockholm, Sweden, ⁶Human Genome Sciences, Inc., Rockville, MD, ⁷Washington Hospital Center, Washington, DC
Background/Purpose: To assess the efficacy of belimumab in patients with SLE who had high disease activity at baseline, as defined by SELENA-SLEDAI score ≥10. Methods: In…
Abstract Number: 2202 • 2012 ACR/ARHP Annual Meeting
Classification Criteria for Sjögren’s Syndrome: Comparison of the Performance of the 2002 American-European Consensus Group Criteria (AECG) and the 2012 ACR Criteria
Elke Theander¹, Peter Olsson² and Thomas Mandl³, ¹Section of Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, ²Section of Rheumatology, Department of Clinical Sciences, Lund University, Malmö, Sweden, ³Dept of Rheumatology, Skåne University Hospital Malmo, Lund University, Sweden, Malmö, Sweden
Background/Purpose: To assess level of agreement between 2002 AECC and 2012 ACR criteria for primary Sjögren's Syndrome syndrome (pSS) within the Malmö Sjögren's Syndrome RegistryMethods…
Abstract Number: 2203 • 2012 ACR/ARHP Annual Meeting
Effects of Reclassification Using the American College of Rheumatology Criteria On a Large cohort Sjögren’s Syndrome Patients
Astrid Rasmussen¹, John A. Ice¹, He Li², Kiely Grundahl³, Jennifer A. Kelly⁴, Lida Radfar⁵, Kimberly S. Hefner⁶, Donald U. Stone⁷, Juan-Manuel Anaya⁸, Michael Rohrer⁹, Glen D. Houston¹⁰, David M. Lewis¹¹, James Chodosh¹², John B. Harley¹³, Pamela Hughes⁹, Jacen S. Maier-Moore⁵, Courtney G. Montgomery¹, Nelson L. Rhodus¹⁴, A. Darise Farris¹⁵, Barbara M. Segal¹⁶, Christopher J. Lessard¹⁷, R. Hal Scofield¹⁸ and Kathy Moser Sivils⁴, ¹Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, ²Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma CIty, OK, ³Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, oklahoma CIty, OK, ⁴Oklahoma Medical Research Foundation, Oklahoma City, OK, ⁵University of Oklahoma Health Sciences Center, Oklahoma City, OK, ⁶Hefner Eye Care and Optical Center, Oklahoma City, OK, ⁷Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, ⁸School of Medicine and Health Sciences, Universidad del Rosario. Center for Autoimmune Diseases Research (CREA), Bogotá, Colombia, ⁹Diagnostic and Biological Sciences, University of Minnesota, Minneapolis, MN, ¹⁰Collage of Denistry, University of Oklahoma Health Sciences Center, Oklahoma City, OK, ¹¹College of Dentistry, University of Oklahoma Health Sciences Center, Oklahoma City, OK, ¹²Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, ¹³Division of Rheumatology and The Center for Autoimmune Genomics & Etiology, University of Cincinnati, Cincinnati Children's Hospital Medical Center; US Department of Veterans Affairs Medical Center, Cincinnati, OH, ¹⁴University of Minnesota, Minneapolis, MN, ¹⁵Arthritis & Immunology Program, Oklahoma Medical Research Foun, Oklahoma City, OK, ¹⁶Rheumatology, Hennepin County Medical Center, Minneapolis, MN, ¹⁷Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation; University of Oklahoma Health Sciences Center, Oklahoma City, OK, ¹⁸Arthritis & Immunology, Oklahoma Medical Research Foun, Oklahoma City, OK
Background/Purpose: There is no single clinical diagnostic test for primary Sjögren’s syndrome (pSS). For research purposes, multiple classification criteria have been proposed over the past…
Abstract Number: 2204 • 2012 ACR/ARHP Annual Meeting
Overall Agreement Between Sjögrens’s Minor Salivary Gland Biopsy and 2002 and 2012 Classification Criteria
Laura Aline Martinez¹, Candido Flores², Alberto Arana Fraustro³ and Luis H. Silveira⁴, ¹Rheumatology, Instituto Nacional de Cardiologia Ignacion Chavez, Mexico City, Mexico, ²Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico, ³Pathology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico, ⁴Rheumatology, Instituto Nacional Cardiología Ignacio Chávez, Mexico City, Mexico
Background/Purpose: Sjögren’s syndrome (SS) is an inflammatory autoimmune disease characterized by lymphoid infiltration of exocrine glands, although extraglandular involvement is frequently observed. Prevalence is around…
Abstract Number: 2205 • 2012 ACR/ARHP Annual Meeting
Longitudinal Evaluation of the Performance of Different Classification Criteria in Patients with Primary Sjögren’s Syndrome
Martina Plešivčnik Novljan¹, ŽIga Rotar², Aleš Ambrožič¹, Gaj Vidmar³ and Matija Tomšič¹, ¹Department of Rheumatology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia, ²Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, ³University Rehabilitation Institute, 1000 Ljubljana, Slovenia
Background/Purpose: Over the past 3 decades, 10 different classification criteria for Sjögren's syndrome (SS) had been proposed. In 2001 and 2002 222 consecutive patients suspected…
Abstract Number: 2206 • 2012 ACR/ARHP Annual Meeting
Patients Fulfilling the Imaging-Arm and Patients Fulfilling the HLA-B27+ Arm of the Assessment of Spondyloarthritis International Society Axial Spondyloarthritis Classification Criteria: Are They Similar?
Rosaline van den Berg¹, Manouk de Hooge¹, Floris van Gaalen¹, Monique Reijnierse², Tom Huizinga¹ and Désirée van der Heijde¹, ¹Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ²Radiology, Leiden University Medical Center, Leiden, Netherlands
Background/Purpose: It is possible to classify patients as having spondyloarthritis (SpA) according to the ASAS axial SpA (axSpA) criteria HLA-B27+ arm without any signs of…
Abstract Number: 2207 • 2012 ACR/ARHP Annual Meeting
How Useful Is Imaging of the Sacroiliac Joints (MRI and/or X-ray) in Patients with Possible Spondyloarthritis in the Diagnostic Work-up?
Rosaline van den Berg¹, Manouk de Hooge¹, Victoria Navarro-Compán¹, Floris van Gaalen¹, Monique Reijnierse², Tom Huizinga¹ and Désirée van der Heijde¹, ¹Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ²Radiology, Leiden University Medical Center, Leiden, Netherlands
Background/Purpose: In daily practice, the diagnostic work-up of patients with possible axial spondyloarthritis (axSpA) starts with clinical and laboratory data. In many patients MRI and/or…
Abstract Number: 2208 • 2012 ACR/ARHP Annual Meeting
Referral Patterns and Diagnosis of Patients with Axial Spondyloarthritis: Results of an International Survey
Désirée van der Heijde¹, Joachim Sieper², Dirk Elewaut³, Aileen L. Pangan⁴ and Dianne Nguyen⁵, ¹Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ²Medical Department I, Rheumatology, Charité Universitätesmedizin Berlin, Berlin, Germany, ³Rheumatology, Department of Rheumatology Ghent University Hospital, Ghent, Belgium, ⁴Abbott Laboratories, Abbott Park, IL, ⁵Abbott Laboratories, Singapore, Singapore
Background/Purpose: This analysis compares referral patterns and diagnostic tools for axial spondyloarthritis (axSpA) used by rheumatologists working in academic centers and in community clinical practice…
Abstract Number: 2209 • 2012 ACR/ARHP Annual Meeting
Assessing Active Inflammation in Sacroiliac Joints in Spondyloarthritis Patients: No Added Value of Gadolinium Compared to Short Tau Inversion Recovery Sequence
Manouk de Hooge¹, Rosaline van den Berg¹, Victoria Navarro-Compán¹, Floris van Gaalen¹, Désirée van der Heijde¹, Tom Huizinga¹ and Monique Reijnierse², ¹Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ²Radiology, Leiden University Medical Center, Leiden, Netherlands
Background/Purpose: MRI is used as a diagnostic tool to detect active disease of the sacroiliac joint. T1 weighted and STIR images are generally used and…
Abstract Number: 2210 • 2012 ACR/ARHP Annual Meeting
The Canada-Denmark Fat Spondyloarthritis Spine Score: Validation of a New Scoring Method for the Evaluation of Fat Lesions in the Spine of Patients with Axial Spondyloarthritis
Susanne Juhl Pedersen¹, Zheng Zhao², Robert GW Lambert³, Mikkel Østergaard⁴, Ulrich Weber⁵ and Walter P. Maksymowych⁶, ¹Dept. of Rheumatology, Copenhagen Center for Arthritis Research, Copenhagen, Denmark, ²Department of Rheumatology, University of Alberta and PLA General Hospital, Beijing, PR China, Beijing, AB, China, ³Radiology, University of Alberta, Edmonton, AB, Canada, ⁴Department of Rheumatology, Glostrup Hospital, Copenhagen, Denmark, ⁵Rheumatology, Balgrist University Hospital, Zurich, Switzerland, ⁶Department of Medicine, University of Alberta, Edmonton, AB, Canada
Background/Purpose: Fat metaplasia has been shown to follow resolution of inflammation in axial SpA and this may be evident within one year (1). Fat metaplasia…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].